Intercept to Present at Upcoming Conference

NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that management will be participating in the following investor conference:

• Needham Healthcare Conference at 12:45 p.m. ET on Wednesday, March 28, 2018

Webcast information for this event will be available on the Investors page of Intercept's website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept's website for approximately two weeks.

About InterceptIntercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept now has operations in the United States, Europe and Canada.

CONTACT: For more information aboutIntercept Pharmaceuticals, please contact:    

Intercept Pharmaceuticals:Mark Vignola+1-646-747-1000[email protected]   

Media inquiries: [email protected]   

Investor inquiries: [email protected]

Source: Intercept Pharmaceuticals, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cardano Price Prediction: ADA Near $0.224 and a Busy Transaction Epoch Meet Remittix’s November Launch Story
• Pacific Mobile Structures Offers Permanent Modular Facilities for Data Centers
• William O. London Named "Attorney of the Month" by Attorney Journals Orange County Edition, October 2026 issue